AI compresses drug discovery timelines from years to months

Generative AI is dramatically shortening drug discovery timelines from years to under 18 months, as demonstrated by Insilico Medicine's accelerated pulmonary fibrosis treatment development. This rapid innovation impacts clinical operators, procurement, and health systems, requiring them to adapt workflows and partnership models to integrate AI-designed therapies and handle AI-informed patient interactions.

This Wire brief sits within Fusion42's coverage of Biotech. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.